Kun-Yuan Chiu
Overview
Explore the profile of Kun-Yuan Chiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Li J, Chen C, Wang S, Yang C, Chiu K, et al.
Ann Surg Oncol
. 2024 Dec;
PMID: 39690386
No abstract available.
2.
Chang L, Hung S, Chen C, Li J, Chiu K, Wang S, et al.
Sci Rep
. 2024 Dec;
14(1):30424.
PMID: 39643608
No abstract available.
3.
Wang C, Wang S, Chen C, Hung S, Chen C, Yang C, et al.
Sci Rep
. 2024 Nov;
14(1):28460.
PMID: 39558010
Bone health screening is crucial before and during androgen deprivation therapy (ADT) for prostate cancer, yet changes in bone mineral density during ADT are often overlooked. To improve surveillance rates,...
4.
Wang Y, Li J, Chen C, Wang S, Yang C, Chiu K, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1354-1363.
PMID: 39550482
Background: This study investigated the utilization of kidney-sparing surgery (KSS) as an alternative option to radical nephroureterectomy (RNU) in managing upper urinary tract urothelial carcinoma (UTUC) patients. Objective: Our study...
5.
Kao W, Chiu K, Tsai S, Teng C, Oner M, Lai C, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Nov;
1871(2):167568.
PMID: 39536992
Aberrant PI3K/Akt activation is linked to prostate cancer (PCa) malignancy, while androgen receptor (AR) is critical in early-stage PCa development. Investigating the interaction between these pathways is crucial for PCa...
6.
Lin C, Wang C, Yang C, Li J, Chen C, Chiu K, et al.
Sci Rep
. 2024 Nov;
14(1):26696.
PMID: 39496647
Prostate cancer (PC) treatment, particularly androgen deprivation therapy (ADT), remains pivotal, albeit linked to increased fracture risk due to osteoporosis. The advent of novel hormonal agents (NHAs) has spurred inquiries...
7.
Lin C, Lee J, Chiu K, Wang S, Chen C, Lin Y, et al.
Medicina (Kaunas)
. 2024 Oct;
60(10).
PMID: 39459459
Ureteral reconstruction is aimed at maintaining ureteral patency without the need for long-term catheters like ureteral stents or percutaneous nephrostomies. Different surgical strategies are adopted based on the etiology, the...
8.
Lai G, Chen C, Cheng J, Li J, Yang C, Lin C, et al.
PLoS One
. 2024 Sep;
19(9):e0309941.
PMID: 39241021
Introduction: Visceral metastasis is an important predictor for poor outcomes in prostate cancer, however, the prognostic significance surrounding the specific sites of visceral metastasis remains unclear. The aim of this...
9.
Huang P, Huang L, Yang C, Li J, Chen C, Wang S, et al.
PLoS One
. 2024 Aug;
19(8):e0306900.
PMID: 39110673
Background: Non-metastatic castration-resistant prostate cancer (nmCRPC) is an asymptomatic condition with the potential to progress to metastasis. Novel hormonal agents (NHAs) are currently considered the gold standard treatment for nmCRPC,...
10.
Lu K, Chiu K, Chen I, Lin G
Kidney360
. 2024 Jul;
5(10):1466-1476.
PMID: 39024039
No abstract available.